Ravantage 9

Company: Huvepharma

(ractopamine hydrochloride Type A medicated article)

Type A Medicated Article

SWINE

For Use in Finishing Swine Feeds Only

Do not feed undiluted.

Active Drug Ingredient: ractopamine hydrochloride - 9 g per lb (20 g per kg)

Important: Must be thoroughly mixed into feeds before use. Follow label directions.

Indication: For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter.

Inert Ingredients: Ground corncobs.

NC = No Change, ↑ = increased, ↓ = decreased,

^a Improvement was observed only in pigs weighing less than 250 lbs.

Mixing Directions: Thoroughly mix Ravantage 9 Type A Medicated Article into one ton of appropriate feed ingredients according to the table below to obtain the proper concentration in the Type B Medicated Feed (maximum 4920 g/ton).

The following table gives examples of how some Type B Medicated Feed concentrations can be prepared:

Thoroughly mix Ravantage 9 Type A Medicated Article into one ton of complete swine feed according to the table below to obtain the proper concentration in the Type C Medicated Feed. Prepare an intermediate pre-blend of the premix prior to mixing in a complete feed. Thoroughly mix the required amount in a convenient quantity of feed ingredients, then add to the remaining feed ingredients to make a ton of complete feed.

Feeding Directions: Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter.

Ravantage 9 Caution

Ractopamine may increase the number of injured and/or fatigued pigs during marketing.

Not for use in breeding swine.

NOT FOR HUMAN USE

Warning

The active ingredient in Ravantage 9, ractopamine hydrochloride, is a beta-adrenergic agonist. Individuals with cardiovascular disease should exercise special caution to avoid exposure. Not for use in humans. Keep out of the reach of children. The Ravantage 9 formulation (Type A Medicated Article) poses a low dust potential under usual conditions of handling and mixing. When mixing and handling Ravantage 9, use protective clothing, impervious gloves, protective eye wear, and a NIOSH-approved dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse eyes thoroughly with water. If irritation persists, seek medical attention. The material safety data sheet contains more detailed occupational safety information. To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet, contact Huvepharma, Inc. at 1-877-994-4883 or www.huvepharma.com. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae.

Storage information: Store at less than or equal to 25°C (77°F).

Excursions to 30°C (86°F) are acceptable. Avoid excessive moisture.

Expiration Date and Lot Number are printed on the bag. Not to be used after the expiry date.

Restricted Drug (California) - Use Only as Directed

Approved by FDA under ANADA # 200-768

Manufactured for: Huvepharma, Inc., 525 Westpark Dr., Ste 230, Peachtree City, GA 30269, U.S.A.

To report adverse effects, access medical information, or obtain additional product information, call 1-877-994-4883.

HUVEPHARMA and Ravantage are trademarks owned or licensed by HUVEPHARMA EOOD, its subsidiaries or affiliates.

Made in Bulgaria.

CPN: 1309095.0